HOT TOPICS IN PHARMACOGNOSY: So What About the Other Half of Kinase Inhibitor Activities?
By David J. Newman, DPhil
INTRODUCTION
Although we have been inundated over the years with stories of the successes with inhibiting protein tyrosine kinases (aka PTKs) and their chemical cousins, based on other amino acids such as serine or threonine…